James Patrick Kelly's Net Worth

$3.45 Million

Estimate Recalculated Nov 11, 2024 02:53AM EST

Who is James Patrick Kelly?

James Patrick Kelly has an estimated net worth of $3.45 Million. This is based on reported shares across multiple companies, which include NOVAVAX INC, SUPERNUS PHARMACEUTICALS, INC., and Vanda Pharmaceuticals Inc..

SEC CIK

James Patrick Kelly's CIK is 0001506314

Past Insider Trading and Trends

2017 was James Patrick Kelly's most active year for acquiring shares with 10 total transactions. James Patrick Kelly's most active month to acquire stocks was the month of December. 2024 was James Patrick Kelly's most active year for disposing of shares, totalling 6 transactions. James Patrick Kelly's most active month to dispose stocks was the month of February. 2024 saw James Patrick Kelly paying a total of $30,676.32 for 195,199 shares, this is the most they've acquired in one year. In 2019 James Patrick Kelly cashed out on 19,788 shares for a total of $434,043.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NOVAVAX INC (NVAX) Snapshot price: $11.6

EVP, CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.61%
1.14K
$12.96
$14,826.24
14.43K
Aug 16
Form 4
—
0
—
—
0
Mar 1
Form 4
+21.85%
2.38K
$5.45
-$12,131.70
13.29K
Mar 10
Form 4
+137.85%
6.32K
$5.61
-$33,127.05
10.9K
Sep 12 - Mar 7
Form 4
+36.39%
1.22K
$7.13
-$8,149.59
4.58K
Aug 16
Form 4
+174.82%
2.14K
$6.52
$13,939.76
3.36K
Mar 10
Form 4
—
0
—
—
0
Mar 7
Form 4
∞
1.22K
$42.88
-$49,054.72
1.22K
Aug 16
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Aug 16
Form 3
—
0
—
—
0
No matching records found

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Snapshot price: $33.84

Executive Vice-President & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Oct 12
Form 3
—
0
—
—
0
No matching records found

Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $5.12

EVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.17%
-18.86K
$10.36
-$195,446.02
186.87K
Mar 2 - Mar 3
Form 4
-1.92%
-4.02K
$15.94
-$64,086.04
205.73K
Jan 2
Form 4
-6.14%
-13.73K
$19.98
-$274,232.50
209.75K
Mar 1 - Mar 4
Form 4
+15.51%
30K
—
—
223.47K
Feb 27
Form 4
-3.04%
-6.06K
$26.37
-$159,810.78
193.47K
Jan 2 - Jan 3
Form 4
+18.72%
31.47K
$18.72
-$159,712.21
199.53K
Feb 28 - Mar 1
Form 4
+1.82%
8.35K
$15.35
-$140,493.55
467.51K
Jan 2
Form 4
+100.40%
70K
—
—
139.72K
Mar 1
Form 4
+14.73%
8.95K
$15.51
-$169,013.05
69.72K
Jan 3
Form 4
—
0
—
—
0
Feb 12
Form 4
+14.01%
7.47K
$8.96
-$85,693.44
60.77K
Jan 4
Form 4
+29.31%
12.08K
$10.53
-$131,098.50
53.3K
Mar 10
Form 4
—
0
—
—
0
Dec 4
Form 4
+43.06%
12.41K
$13.46
-$95,889.04
41.22K
Feb 18
Form 4
—
0
—
—
0
Dec 2
Form 4
-10.41%
-3.35K
$12.07
-$40,420.74
28.82K
Nov 19
Form 4
+41.14%
9.38K
—
—
32.16K
Jul 29
Form 4
+81.15%
10.21K
$3.95
-$27,563.10
22.79K
Feb 14
Form 4
—
0
—
—
0
Dec 7
Form 4
+151.60%
7.58K
$4.67
-$22,994.11
12.58K
Feb 16
Form 4
—
0
—
—
0
Dec 6
Form 4
∞
5K
$5.99
$29,952.00
5K
Aug 29
Form 4/A
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Dec 13
Form 3
—
0
—
—
0
No matching records found